Silverii, Giovanni Antonio

Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials

Silverii, G. A., Monami, M., Gallo, M., Ragni, A., Prattichizzo, F., Renzelli, V., Ceriello, A., & Mannucci, E. (2024) · Diabetes Obesity and Metabolism

Thyroid Cancer Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 113

GLP ‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials

Silverii, G. A., Marinelli, C., Bettarini, C., Del Vescovo, G. G., Monami, M., & Mannucci, E. (2025) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 67

Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

Silverii, G. A., Pala, L., Cresci, B., & Mannucci, E. (2025) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 49

Effectiveness of intermittent fasting for weight loss in individuals with obesity: A meta-analysis of randomized controlled trials

Silverii, G. A., Cresci, B., Benvenuti, F., Santagiuliana, F., Rotella, F., & Mannucci, E. (2023) · Nutrition, Metabolism and Cardiovascular Diseases

Dietary Effects on HealthDiet and metabolism studies

Cited by 34

Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes

Silverii, G. A. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 33

Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events

De Luca, M., Zese, M., Silverii, G. A., Ragghianti, B., Bandini, G., Forestieri, P., Zappa, M. A., Navarra, G., Foschi, D., Musella, M., et al. (2023) · Obesity Surgery

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 28

Cardiovascular prevention with glucose‐lowering drugs in type 2 diabetes: An evidence‐based approach to the categories of primary and secondary prevention

Mannucci, E., & Silverii, G. A. (2023) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 16